Company profile: IconOVir Bio
1.1 - Company Overview
Company description
- Provider of preclinical oncolytic virus therapies for cancer, developing ICVB-1042, an oncolytic adenovirus for advanced solid tumors featuring tumor-selective replication, broad tropism, and enhanced tumor cell killing.
Products and services
- Oncolytic Virus Therapy Development: Preclinical-stage program that develops oncolytic virus therapy for treating patients with cancer, architected to target malignancies and intensify tumor cell killing
- ICVB-1042: Adenovirus-based oncolytic therapy for advanced solid tumors, engineered for tumor-selective replication, broad tropism across malignant tissues, and enhanced tumor cell killing capacity
- Advanced Solid Tumor Oncolytic Programs: Tumor-selective effort focused on treating advanced solid tumors in cancer patients, leveraging broad tropism to expand targeting and enhance tumor cell killing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IconOVir Bio
Step Pharma
HQ: France
Website
- Description: Provider of CTPS1 inhibition therapies, developing STP938, an orally bioavailable CTPS1 inhibitor in clinical development for treating blood cancers and potentially solid tumors. The approach targets the CTPS1 enzyme to inhibit a key step in nucleotide synthesis to treat various cancers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Step Pharma company profile →
Onco-NX
HQ: United Kingdom
Website
- Description: Provider of drug discovery research dedicated to identifying new promising anticancer agents as a University of Salford spin-out company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Onco-NX company profile →
Actinium Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical, radiotherapies, and medical research, development, and clinical trial services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Actinium Pharmaceuticals company profile →
Empirica Therapeutics
HQ: Canada
Website
- Description: Provider of therapeutic drugs focused on adoptive immunotherapies targeting aggressive, treatment-resistant cancers, including glioblastoma and brain metastasis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Empirica Therapeutics company profile →
QSAM Biosciences
HQ: United States
Website
- Description: Provider of nuclear medicines for the treatment of cancer and related diseases and conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QSAM Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IconOVir Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IconOVir Bio
2.2 - Growth funds investing in similar companies to IconOVir Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IconOVir Bio
4.2 - Public trading comparable groups for IconOVir Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →